Posted On: 02/02/2016 7:01:44 AM
Post# of 5066
Well the 10Q made me cross eyed. Lots there. Only one error I could see, not big, just date. Other than that, sheesh, looks like something may happen here by August or so. There are notes out there. It might be worth sitting on the bid in March if a person wants 2,s.
The debt is building big now in BMSN, and the A/S is HUGE and only half there (o/s). Financials cast a big shadow but being a clinical stage company and small molecules in pipeline is hard to overshadow.
I wish I could share a good guess about what might happen next for BMSN, but I am stumped. Even an RS is not likely to happen for a long time if at all. The big thing needed here is patience.
The debt is building big now in BMSN, and the A/S is HUGE and only half there (o/s). Financials cast a big shadow but being a clinical stage company and small molecules in pipeline is hard to overshadow.
I wish I could share a good guess about what might happen next for BMSN, but I am stumped. Even an RS is not likely to happen for a long time if at all. The big thing needed here is patience.
(0)
(0)
